Mesirow Financial Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46M Buy
91,809
+1,426
+2% +$685K 0.72% 34
2026
Q1
$44.4M Buy
90,383
+5,963
+7% +$3.24M 0.72% 29
2025
Q4
$48.9M Sell
84,420
-4,991
-6% -$2.82M 1% 22
2025
Q3
$43.4M Buy
89,411
+982
+1% +$457K 0.78% 27
2025
Q2
$35.9M Buy
88,429
+381
+0.4% +$159K 0.7% 34
2025
Q1
$43.8M Sell
88,048
-2,793
-3% -$1.51M 0.85% 23
2024
Q4
$47.3M Buy
90,841
+337
+0.4% +$185K 0.94% 21
2024
Q3
$56M Sell
90,504
-196
-0.2% -$116K 1.08% 20
2024
Q2
$50.2M Sell
90,700
-596
-0.7% -$341K 1.13% 16
2024
Q1
$53.1M Sell
91,296
-304
-0.3% -$171K 1.21% 16
2023
Q4
$3.31M Buy
+91,600
New +$44.3M 0.12% 113

Other funds holding TMO

Mesirow Financial Investment Management's TMO Position: Q2 2026 in Review

Mesirow Financial Investment Management increased its Thermo Fisher Scientific (TMO) stake by 1.6% in Q2 2026, buying an estimated $685K and bringing the position to 91,809 shares worth $46M. The position accounts for 0.72% of the portfolio, ranked #34.

Mesirow Financial Investment Management first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $56M in Q3 2024. 1,497 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Mesirow Financial Investment Management held 91,809 shares of Thermo Fisher Scientific worth $46M as of Q2 2026.
  • Mesirow Financial Investment Management bought 1,426 Thermo Fisher Scientific shares in Q2 2026, an estimated $685K.
  • Thermo Fisher Scientific made up 0.72% of Mesirow Financial Investment Management's portfolio in Q2 2026, its #34 holding.
  • Mesirow Financial Investment Management first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • Mesirow Financial Investment Management's Thermo Fisher Scientific position peaked at $56M in Q3 2024.
  • 1,497 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.